193 related articles for article (PubMed ID: 2245390)
1. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
[TBL] [Abstract][Full Text] [Related]
2. [Transfusion-associated graft-vs-host disease in a patient with Hodgkin's disease].
Lillevang ST; Andersen CB; Schmidt KG; Riisom K
Ugeskr Laeger; 1992 Oct; 154(43):2979-80. PubMed ID: 1462387
[TBL] [Abstract][Full Text] [Related]
3. Graft versus host disease following transfusion of normal blood products to patients with malignancies.
Kessinger A; Armitage JO; Klassen LW; Landmark JD; Hayes JM; Larsen AE; Purtilo DT
J Surg Oncol; 1987 Nov; 36(3):206-9. PubMed ID: 3316850
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
Labotka RJ; Radvany R
Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-associated graft-versus-host disease in patients with Hodgkin's disease and T cell lymphoma.
Baglin TP; Joysey VC; Horsford J; Johnson RT; Broadbent V; Marcus RE
Transfus Med; 1992 Sep; 2(3):195-9. PubMed ID: 1308830
[TBL] [Abstract][Full Text] [Related]
6. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
Shivdasani RA; Anderson KC
Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
[TBL] [Abstract][Full Text] [Related]
7. [Post-transfusion graft versus host disease in a patient with Hodgkin's disease].
Tomás Martínez JF; Abad Hernández MJ; Cortina de la Calle MP; Canut Blasco A; Nieto González MJ; Corral Alonso M; San Miguel Izquierdo JF; López-Borrasca A
Med Clin (Barc); 1989 Apr; 92(13):503-6. PubMed ID: 2747313
[TBL] [Abstract][Full Text] [Related]
8. Acute graft-versus-host disease resulting from normal donor blood transfusions.
Burns LJ; Westberg MW; Burns CP; Klassen LW; Goeken NE; Ray TL; Macfarlane DE
Acta Haematol; 1984; 71(4):270-6. PubMed ID: 6426240
[TBL] [Abstract][Full Text] [Related]
9. [Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates].
Heim MU; Munker R; Sauer H; Wolf-Hornung B; Knabe H; Holler E; Böck M; Mempel W
Beitr Infusionsther; 1992; 30():178-81. PubMed ID: 1284701
[TBL] [Abstract][Full Text] [Related]
10. [A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion].
Nakamoto T; Nishi S; Shindoh M; Hayashi M; Yukioka H; Fujimori M; Maekawa N
Masui; 1995 Sep; 44(9):1261-4. PubMed ID: 8523663
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells.
Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y
Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-associated graft-versus-host disease in an immunocompetent patient following accidental injury.
Kobayashi H; Kitano K; Kishi E; Hara K; Ishida F; Saito H; Ota M; Furuta S
Am J Hematol; 1993 May; 43(1):51-3. PubMed ID: 8317463
[TBL] [Abstract][Full Text] [Related]
13. Transfusion associated graft versus host disease in an immunocompetent patient.
O'Connor NT; Mackintosh P
J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
[TBL] [Abstract][Full Text] [Related]
14. Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.
Dinsmore RE; Straus DJ; Pollack MS; Woodruff JM; Garrett TJ; Young CW; Clarkson BD; Dupont B
Blood; 1980 May; 55(5):831-4. PubMed ID: 7362871
[TBL] [Abstract][Full Text] [Related]
15. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.
Peggs KS; Hunter A; Chopra R; Parker A; Mahendra P; Milligan D; Craddock C; Pettengell R; Dogan A; Thomson KJ; Morris EC; Hale G; Waldmann H; Goldstone AH; Linch DC; Mackinnon S
Lancet; 2005 Jun 4-10; 365(9475):1934-41. PubMed ID: 15936420
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature.
Decoste SD; Boudreaux C; Dover JS
Arch Dermatol; 1990 Oct; 126(10):1324-9. PubMed ID: 2221937
[TBL] [Abstract][Full Text] [Related]
17. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
[TBL] [Abstract][Full Text] [Related]
18. [Acute graft-versus-host disease following a single transfusion of erythrocytes].
Gössi U; Bucher U; Brun del Re G; Miloni E; Hess T
Schweiz Med Wochenschr; 1985 Jan; 115(2):34-40. PubMed ID: 3969540
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated graft-versus-host disease and its prevention.
Williamson LM; Warwick RM
Blood Rev; 1995 Dec; 9(4):251-61. PubMed ID: 8839400
[TBL] [Abstract][Full Text] [Related]
20. HLA-matched blood products and posttransfusion graft-versus-host disease.
Charpentier F; Bracq C; Bonin P; Berling P; Duedari N
Transfusion; 1990; 30(9):850. PubMed ID: 2238036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
